Negative Symptom and Cognitive Deficit Treatment Response in Schizophrenia Tapa dura - 2001

Amer Psychiatric Pub, 2001-01. Hardcover. Good.

American Psychiatric Association Publishing. Used - Very Good. Ships from the UK. Former library book; may include library markings. Used book that is in excellent condition. May show signs of wear or have minor defects.

Hardback. New. For the first time in a single volume, distinguished experts address the complex issues -- issues rarely confronted in empirical studies of patients with schizophrenia -- and controversial research surrounding the assessment of negative symptoms and cognitive deficits in patients with schizophrenia.

Amer Psychiatric Pub Inc, 2001. Hardcover. New. 201 pages. 9.25x6.25x1.00 inches.

Arlington, Virginia, U.S.A.: Amer Psychiatric Pub Inc. New. 2000. Hardcover. 0880487852 .*** FREE UPGRADE to Courier/Priority Shipping Upon Request *** - *** IN STOCK AND IMMEDIATELY AVAILABLE FOR SHIPMENT - BRAND NEW, FLAWLESS COPY, NEVER OPENED -- 216 pages. "Despite recent advances in our understanding of schizophrenia, still notably absent is consensus in assessing negative symptom treatment response. What is the most effective assessment method—given the varying methodologies and contradictory results to date? What constitutes an adequate response? Which medication—none is specifically indicated and licensed for negative symptom treatment—yields the best results? What are the indications for use of this medication? Which instrument best measures negative symptom treatment response (eight rating scales are analyzed here)? Reaching consensus among clinicians and researchers alike is even more difficult because assessment is often thwarted by extrapyramidal… Leer más

Arlington, Virginia, U.S.A.: Amer Psychiatric Pub Inc. New. 2000. Hardcover. 0880487852 .*** FREE UPGRADE to Courier/Priority Shipping Upon Request *** - *** IN STOCK AND IMMEDIATELY AVAILABLE FOR SHIPMENT - 201 pages -- -- DESCRIPTION: Experts address the complex issues rarely confronted in empirical studies of patients with schizophrenia, and controversial research surrounding the assessment of negative symptoms and cognitive deficits in patients with schizophrenia. Includes vignettes. -- with a bonus offer-- .